Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 5 results

Firm News | 2 min read | 02.21.25

Crowell & Moring, Planned Parenthood Federation of America, ACLU of Missouri, and ACLU Reproductive Freedom Project Achieve Victory in Reproductive Rights Case in Missouri

Washington – February 21, 2025: Missouri health care providers will be able to resume abortion care after a Jackson County Circuit judge temporarily blocked the Targeted Regulation of Abortion Providers (TRAP) last week. The TRAP restriction, Missouri’s abortion facility licensure requirement, had been left in place in a previous ruling and prevented providers, like Planned Parenthood, from resuming care, despite the state’s voters’ enacting an amendment on November 5, 2024, to enshrine a right to reproductive freedom in the Missouri Constitution. With this ruling, Missouri becomes the first state in the nation to restore abortion access after a total ban.

Firm News | 8 min read | 01.09.23

Crowell & Moring Elects 16 New Partners, Promotes Five to Senior Counsel, and 25 to Counsel

Crowell & Moring elected 16 lawyers to the firm’s partnership, effective January 1, 2023. The firm also promoted five lawyers to the position of senior counsel and 25 associates to the position of counsel.

Firm News | 2 min read | 09.16.21

Crowell & Moring and ACLU of Maryland Achieve Victory in Removal of the Last Confederate Statue on Public Grounds in Maryland

Washington – September 16, 2021: The Talbot County Council has adopted a resolution to remove the last Confederate statue remaining on public grounds in Maryland. This is a change of position for the Council and follows a lawsuit filed by Crowell & Moring and the American Civil Liberties Union of Maryland. The resolution, passed on September 14, 2021 with a 3-2 vote, orders the movement of the Talbot Boys statue from the Easton courthouse to a private park in Virginia “as soon as is practicable.”
...

Client Alerts 16 results

Client Alert | 7 min read | 06.26.26

Federal Roundup: Updates for PBMs and Medicare Advantage Organizations

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
...

Client Alert | 6 min read | 04.29.26

CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)

On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
...

Client Alert | 5 min read | 04.07.26

Weight-Loss Drug Coverage Obligations: A Litigation and Regulatory Update

As pharmaceutical weight-loss therapies have surged in popularity, health plans, regulators, and courts have found themselves grappling with a set of increasingly pressing and complex questions: who must cover these drugs, under what circumstances, and for whom?
...

Press Coverage 2 results